Zomedica Pharmaceuticals (ZOM) Increase Bought Deal Size to $173.5M from $25M on Demand
Get Alerts ZOM Hot Sheet
Join SI Premium – FREE
Zomedica Corp. (NYSE American: ZOM), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today announced that, due to demand, the underwriter has agreed to increase the size of the previously announced public offering and purchase on a firm commitment basis 91,315,790 common shares of Zomedica, at a price to the public of $1.90 per share, less underwriting discounts and commissions. The closing of the offering is expected to occur on or about February 11, 2021, subject to satisfaction of customary closing conditions.
H.C. Wainwright & Co. is acting as the sole book-running manager for the offering.
Zomedica also has granted to the underwriter a 30-day option to purchase up to 13,697,368 additional common shares at the public offering price, less underwriting discounts and commissions.
The gross proceeds are expected to be approximately $173.5 million, before deducting underwriting discounts and commissions and other offering expenses payable by Zomedica. Zomedica intends to use the net proceeds from the offering for the continued development of its diagnostic platforms, including making milestone payments, if any, as they come due, under its existing license and collaboration agreements, for strategic acquisitions if and when they become available, and other general corporate and working capital purposes and may use a portion of the net proceeds to repurchase some or all of its outstanding Series 1 Preferred Shares, although no agreement has been reached with respect to the terms or conditions of any such repurchase.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Praxis Precision Medicines (PRAX) Announces Proposed Share Offering
- Allegion plc (ALLE) Files Mixed Shelf
- Cheetah Net Supply Chain Service Inc (CTNT) Announces 10M Share Offering
Create E-mail Alert Related Categories
Corporate News, Equity Offerings, Trader TalkRelated Entities
S3, H.C. WainwrightSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!